MidAmerica Division — Kansas City, Missouri

MidAmerica Division is a clinical research site located in Kansas City, Missouri, United States 64132.

Crixeo Clinical Trials Trust Score: 17/100 (FAILING). This profile has not yet been claimed by the site owner.

MidAmerica Division has participated in 8 clinical trials with 1 currently active.

Therapeutic areas: Pancreas Adenocarcinoma, Myelofibrosis (MF), Myelodysplastic Syndrome (MDS).

Sponsors: NovoCure Ltd., AbbVie, Marker Therapeutics, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Kansas City

Browse all research sites in Missouri · View every site in Kansas City

Sponsor Feasibility Report

Trust Score: 17/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MidAmerica Division?

MidAmerica Division has a Crixeo Trust Score of 17/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MidAmerica Division conducted?

MidAmerica Division has 8 clinical trials on record, with 1 currently active. Their work covers Pancreas Adenocarcinoma, Myelofibrosis (MF), Myelodysplastic Syndrome (MDS).

Is MidAmerica Division accredited by Crixeo Clinical Trials?

MidAmerica Division has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MidAmerica Division?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.